In a retrospective clinical study (n = 80), oral supplementation with omega-3 PUFAs has significantly lowered proinflammatory procalcitonin and IL-6 levels and reduced prothrombin time in ICU/hospitalized COVID-19 patients718. Here, IL6 is linked to COVID-19.